End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2063 USD | -13.28% | +13.41% | +4.19% |
May. 20 | Onconetix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 11 | Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | 0.06 | Capitalization | 3.64M |
---|---|---|---|---|---|
Net income 2022 | -13M | Net income 2023 | -37M | EV / Sales 2022 | - |
Net cash position 2022 | 25.75M | Net Debt 2023 | 5.33M | EV / Sales 2023 | 153,458,137 x |
P/E ratio 2022 |
-1
x | P/E ratio 2023 |
-0.09
x | Employees | 12 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.63% |
1 day | -13.28% | ||
1 week | +13.41% | ||
1 month | +82.57% | ||
3 months | +12.00% | ||
6 months | -20.62% | ||
Current year | +4.19% |
Managers | Title | Age | Since |
---|---|---|---|
Ralph Schiess
CEO | Chief Executive Officer | 46 | Dec. 14 |
Bruce Harmon
DFI | Director of Finance/CFO | 66 | 23-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
BRD | Director/Board Member | 62 | Feb. 05 |
Ajit Singh
BRD | Director/Board Member | 60 | Feb. 06 |
James Sapirstein
CHM | Chairman | 63 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.2063 | -13.28% | 3,873,021 |
24-05-30 | 0.2379 | -19.33% | 15,960,286 |
24-05-29 | 0.2949 | +79.93% | 137,820,137 |
24-05-28 | 0.1639 | -9.90% | 2,209,938 |
End-of-day quote Nasdaq, May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+4.19% | 4.61M | |
-1.85% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+62.80% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+6.07% | 9.11B |
- Stock Market
- Equities
- ONCO Stock